Laboratoires Goemar S.A.
Records under this name other than patents Laboratoires Goemar S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Laboratoires Goemar S.A.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,979,665 | Agent for stimulation of the natural defences of plants and methods for using it Term ended Term ended Mar 12, 2023 · USPTO record | Term ended | Term ended Mar 12, 2023 | USPTO record |
| US 6,451,352 | Use of iso-osmotic saline solutions, method for preparing same and medicine based on said solutions Formerly held Term ended Term ended May 24, 2021 · USPTO record | Term ended | Term ended May 24, 2021 | USPTO record |
| US 6,511,838 | Genes coding for &bgr;-agarases and their use for producing agar biodegradation enzymes Term ended Term ended Dec 12, 2020 · USPTO record | Term ended | Term ended Dec 12, 2020 | USPTO record |
| US 6,387,847 | Method for stimulating natural control system of plants Term ended Term ended Jan 18, 2020 · USPTO record | Term ended | Term ended Jan 18, 2020 | USPTO record |
| US 6,984,630 | Endofucanases and method using same for preparing fuco-oligosaccharides from fucanes, bacterium producing endofucanases and uses of fuco-oligosaccharides for plant protection Term ended Term ended Sep 21, 2019 · USPTO record | Term ended | Term ended Sep 21, 2019 | USPTO record |
| US 6,921,540 | Hypoosmotic saline solutions, method for preparing same and medicines based on said solution Formerly held Term ended Term ended Jul 5, 2019 · USPTO record | Term ended | Term ended Jul 5, 2019 | USPTO record |
| US 6,333,185 | Glycosyl hydrolase genes and their use for producing enzymes for the biodegradation of carrageenans Term ended Term ended Apr 5, 2019 · USPTO record | Term ended | Term ended Apr 5, 2019 | USPTO record |
| US 7,008,931 | Anti-inflammatory and healing medicine based on laminarin sulphate Lapsed on the fee record Ended Mar 7, 2018 · USPTO record | Lapsed on the fee record | Ended Mar 7, 2018 | USPTO record |
| US 7,671,040 | Chemotherapeutic antineoplastic treatment Lapsed on the fee record Ended Mar 2, 2018 · USPTO record | Lapsed on the fee record | Ended Mar 2, 2018 | USPTO record |
| US 6,830,915 | Glycosyl hydrolase genes and their use for producing enzymes for the biodegradation of carrageenans Term ended Term ended Oct 6, 2017 · USPTO record | Term ended | Term ended Oct 6, 2017 | USPTO record |